Serum neopterin and complex stenosis morphology in patients with unstable angina.
about
Immune activation and degradation of tryptophan in coronary heart diseaseNeopterin measurement in clinical diagnosis.Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromesNeopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesionsAssociation between serum neopterin and inflammatory activation in chronic kidney disease.Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromesGender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures.Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing.The role of immune activation in endotoxin-induced atherogenesis.The increased histamine release in ischaemic heart disease patients undergoing coronaroangiography is not mediated by specific IgE.HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease.Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation.Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction.Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease.Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.Estimation of serum neopterin in patients with acute coronary syndrome.Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells.Atherogenesis and Inflammation
P2860
Q28180117-CF89B617-FE3E-439C-A7A6-51D16315BCEFQ34419180-B8C4F2EE-FF50-4F50-B694-6BF5756B45F2Q35582637-E65A493E-EBFB-4062-8CB0-74BD2E28145BQ36172876-AD1C5927-B108-48BC-B740-D8854E23B2E8Q36206630-9C3A8858-3163-4AB0-8A6E-ECB5AB6CB9E3Q36484657-77D36412-CB3B-46D1-8AD5-25654E511864Q37276495-C9D4DB88-5B87-4AB5-83B2-2E1F5B8E7BAEQ37919535-F3861774-0508-4EB9-8AEE-AF2B385B3B56Q40449493-F1CC9E71-B4F2-4CBF-8F48-DB2EC1BAC77CQ43122848-828FD247-CDAA-40D2-BE95-048A2E22D6CCQ43805487-A8A7D094-C9F3-4B80-B2BC-0854395189A8Q44080533-225E6536-8C78-471F-990C-635DFE2377B7Q44633043-BA11854D-FD61-4D67-B115-69C186494CD2Q45118470-999FD144-9357-4E7E-8E42-644A4E438C5FQ46092121-77679DF5-DCD0-4F73-B7EA-04A9D09714D9Q46328323-A5EC9D75-72BF-4E02-99DD-8A2A30652968Q51745188-07123FDD-815D-41C0-8025-AE4BE5DE8538Q54374871-014899F8-5C23-44A5-A9B5-925A92FA6632Q54592153-1537B6B2-405E-4F5B-8B9B-7E1DEFEFDEECQ58492104-17B53313-134C-4F2C-A442-F464A14D0250
P2860
Serum neopterin and complex stenosis morphology in patients with unstable angina.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Serum neopterin and complex stenosis morphology in patients with unstable angina.
@en
Serum neopterin and complex stenosis morphology in patients with unstable angina.
@nl
type
label
Serum neopterin and complex stenosis morphology in patients with unstable angina.
@en
Serum neopterin and complex stenosis morphology in patients with unstable angina.
@nl
prefLabel
Serum neopterin and complex stenosis morphology in patients with unstable angina.
@en
Serum neopterin and complex stenosis morphology in patients with unstable angina.
@nl
P2093
P1476
Serum neopterin and complex stenosis morphology in patients with unstable angina
@en
P2093
P304
P356
10.1016/S0735-1097(99)00640-3
P407
P577
2000-03-01T00:00:00Z